Published in Oncology
Journal Scan / Research · July 14, 2022
Comparable Effectiveness of 45- and 20-Minute Post-Infusion Scalp Cooling Time in Preventing Paclitaxel-Induced Alopecia
Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer
"Despite the progress made in delivering scalp cooling effectively, it remains underutilized. One reason for lack of use is the perceived burden on infusion center resources based on the need to perform prolonged scalp cooling both before and especially after the initation and completion of each chemotherapy session. This multi-center clinical trial, just published in Supportive Care and Cancer, studied reducing post-infusion cooling time after weekly paclitaxel to 20 minutes and demonstrated similar success rate of 75% compared to the usual 90-minute post infusion cooling. Adapting this reduced time is more convenient for patients and impacts minimally on infusion centers. More centers should adopt this effective intervention, so a broader group of patients have access to scalp cooling and its beneficial effects."